Loading data
GEVONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 160.58 m USD | 16.92 m USD | 17.2 m USD | 1.18 m USD | 533 k USD |
| Gross profit | — | — | — | — | -11.45 m USD |
| Research and development expense | 4.55 m USD | 5.58 m USD | 6.64 m USD | 7.43 m USD | 6.78 m USD |
| Selling, general and administrative expense | — | — | — | — | 25.49 m USD |
| Operating profit | -20.21 m USD | -90.82 m USD | -81.84 m USD | -102.69 m USD | -60.27 m USD |
| Interest expense | — | — | 2.16 m USD | 1.17 m USD | 251 k USD |
| Net income (reported basis) | -33.84 m USD | -78.64 m USD | -66.22 m USD | -98.01 m USD | -59.2 m USD |
| Net income attributable to common shareholders | — | -78.64 m USD | -66.22 m USD | -98.01 m USD | -59.2 m USD |
| Basic earnings per share | -0.14 USD/share | -0.34 USD/share | -0.28 USD/share | -0.44 USD/share | -0.3 USD/share |
| Diluted earnings per share | -0.14 USD/share | -0.34 USD/share | -0.28 USD/share | -0.44 USD/share | -0.3 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.